Preliminary experiences closing secundum atrial septal defect using the modified Cardia Intrasept™ device

Massimo Chessa, Gianfranco Butera, Mario Carminati

Research output: Contribution to journalArticle


During the past decade, transcatheter occlusion of secundum atrial septal defects (Type II ASDs) has become a widely accepted alternative to surgical closure. To date, over 6,000 patients have been treated with the Cardia Intrasept™ PFO occluder (Cardia Inc., Burnsville, Minnesota) for the percutaneous closure of patent foramen ovale (PFO). This is a report of the use of a modified Intrasept device to close Type II ASDs in 4 patients.

Original languageEnglish
Pages (from-to)142-144
Number of pages3
JournalJournal of Invasive Cardiology
Issue number3
Publication statusPublished - Mar 2007


ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this